Latest Biologics News and Updates : Biologics updates, Biologics News , Biologics around the world

Nishadil

Washington | 21°C (broken clouds)

The Future of US Pharma: Dr. Reddy's CEO Predicts Biosimilars to Eclipse Generics by Early 2030s

Top story

The Future of US Pharma: Dr. Reddy's CEO Predicts Biosimilars to Eclipse Generics by Early 2030s

In focus

Latest feed

The Pharmaceutical Frontier: Biosimilars on the Rise

Bristol Myers Squibb Announces Significant Operational Shift in Devens, Leading to Job Losses

Unlocking Affordable Medicine: A Call for Smarter Biosimilar Regulation

Understanding Crohn's Disease: A Comprehensive Guide

Latest headlines

The Intricate Dance of IBD: Unraveling the Future of Truly Personalized Treatment

The Intricate Dance of IBD: Unraveling the Future of Truly Personalized Treatment

The Great Pharmaceutical Gridlock: How Patents Keep Prices Sky-High and Biosimilars at Bay

The Great Pharmaceutical Gridlock: How Patents Keep Prices Sky-High and Biosimilars at Bay

A New Dawn for Cancer Care: FDA Taps Veteran Scientist Richard Pazdur to Lead Groundbreaking Initiative

A New Dawn for Cancer Care: FDA Taps Veteran Scientist Richard Pazdur to Lead Groundbreaking Initiative

Florida's Arthritis Patients Face a Looming Threat: Is Washington's Drug Pricing Plan Stifling the Hope for New Cures?

Florida's Arthritis Patients Face a Looming Threat: Is Washington's Drug Pricing Plan Stifling the Hope for New Cures?

The Looming Storm: How Trade Tensions Could Reshape the World's Pharmacy

The Looming Storm: How Trade Tensions Could Reshape the World's Pharmacy

A Whisper Becomes a Roar: Unpacking the Turmoil at FDA's Biologics Hub

A Whisper Becomes a Roar: Unpacking the Turmoil at FDA's Biologics Hub

The Great Weigh-In: Pharma's Fierce Battle for the Future of Obesity, and What Else Keeps Them Up at Night

The Great Weigh-In: Pharma's Fierce Battle for the Future of Obesity, and What Else Keeps Them Up at Night

The Biologic Revolution: Unpacking the Promise and Price of Tomorrow's Cures

The Biologic Revolution: Unpacking the Promise and Price of Tomorrow's Cures

The Shifting Sands of Pharma: Why India's CDMOs Face a Defining Moment of Specialization

The Shifting Sands of Pharma: Why India's CDMOs Face a Defining Moment of Specialization

North Carolina's Biotech Boom: Powering the Future of Medicine Through Advanced Manufacturing

North Carolina's Biotech Boom: Powering the Future of Medicine Through Advanced Manufacturing

A New Chapter: Peter Marks, Former FDA Vaccine Czar, Lands at Eli Lilly

A New Chapter: Peter Marks, Former FDA Vaccine Czar, Lands at Eli Lilly

The Biotech & Pharma Services Market: A Decade of Explosive Growth Towards $130 Billion

The Biotech & Pharma Services Market: A Decade of Explosive Growth Towards $130 Billion

Unlocking the Future of Medicine: Protein Expression Market Set for Explosive Growth to $6.60 Billion by 2032

Unlocking the Future of Medicine: Protein Expression Market Set for Explosive Growth to $6.60 Billion by 2032

Regeneron's Growth Horizon: Beyond the Core, Towards New Frontiers

Regeneron's Growth Horizon: Beyond the Core, Towards New Frontiers

South Korean Pharma Giant Celltrion Seals $330M Deal for Eli Lilly's U.S. Biologics Facility

South Korean Pharma Giant Celltrion Seals $330M Deal for Eli Lilly's U.S. Biologics Facility

Trump's Ambitious Drug Tax Plan: A High-Stakes Bet on American Healthcare

Trump's Ambitious Drug Tax Plan: A High-Stakes Bet on American Healthcare

Cambrex Revolutionizes Peptide Manufacturing with Major Waltham Expansion

Cambrex Revolutionizes Peptide Manufacturing with Major Waltham Expansion

Load more